Authors: Eron, JJ Haubrich, R Lang, W Pagano, G Millard, J Wolfram, J Snowden, W Pedneault, L Tisdale, M

Citation: Jj. Eron et al., A phase II trial of dual protease inhibitor therapy: Amprenavir in combination with indinavir, nelfinavir, or saquinavir, J ACQ IMM D, 26(5), 2001, pp. 458-461

Authors: Slater, MJ Baxter, R Bonser, RW Cockerill, S Gohil, K Parry, N Robinson, E Randall, R Yeates, C Snowden, W Walters, A

Citation: Mj. Slater et al., Synthesis of N-alkyl substituted indolocarbazoles as potent inhibitors of human cytomegalovirus replication, BIOORG MED, 11(15), 2001, pp. 1993-1995

Authors: Tisdale, M Myers, R Randall, S Maguire, M Ait-Khaled, M Elston, R Snowden, W

Citation: M. Tisdale et al., Resistance to the HIV protease inhibitor amprenavir in vitro and in clinical studies - A review, CLIN DRUG I, 20(4), 2000, pp. 267-285

Authors: Slater, MJ Cockerill, S Baxter, R Bonser, RW Gohil, K Gowrie, C Robinson, JE Littler, E Parry, N Randall, R Snowden, W

Citation: Mj. Slater et al., Indolocarbazoles: Potent, selective inhibitors of human cytomegalovirus replication, BIO MED CH, 7(6), 1999, pp. 1067-1074

Authors: Snowden, W

Citation: W. Snowden, Calculated risks, PSYCHOLOGIS, 12(6), 1999, pp. 281-281